NCT05088681

Brief Summary

This is a multicenter observational study aimed to characterize multi-muscle synergy organization in relation to postural stability in individuals with Peripheral Neuropathies (PN) compared to healthy age-matched subjects and to assess the effectiveness of a rehabilitation program driven by multi-muscle synergy organization.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 3, 2021

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

September 11, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 22, 2021

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

January 2, 2024

Status Verified

December 1, 2023

Enrollment Period

2.6 years

First QC Date

September 11, 2021

Last Update Submit

December 29, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • Evaluation of multi-muscle synergy organization using Synergy Index (SI)

    Multi-muscle Synergy Index (SI) are new measurements of postural stability and a proxy of multi-muscle coordination. Synergy has been defined as a neural organization of a large set of effectors (e.g., muscles) providing stability of salient performance variables (e.g., center of pressure, COP). Within this framework, SI has been introduced, reflecting the relative amount of inter-trial variance that does not affect a performance variable.

    At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

  • Evaluation of change in Anticipatory Synergy Adjustments (ASA)

    ASAs represent changes in an index of a multi-muscle synergy stabilizing the coordinate of the center of pressure (COP). Such changes may be seen in young, healthy persons about 200-300 ms prior to the action initiation.

    At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

  • Evaluation of balance

    Evaluation of balance using Mini Balance Evaluation System Test (MiniBESTest). Each item is scored on a 0-4 scale; the scores are summed to obtain a total score of 28. The item are divided in four sessions: anticipatory, reactive postural control, sensory orientation, dynamic gait.

    At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

  • Evaluation of balance

    Evaluation of balance using Timed Up and Go test (TUG). It is a measure of the time taken by the patient for rising from a chair, walking three meters, turning and walking back to the chair to sit down.

    At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

  • Evaluation of mobility

    Evaluation of mobility using Six Minute Walking Test (6MWT). The 6MWT assesses distance walked over six minutes as a sub-maximal test of endurance/aerobic capacity.

    At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

Secondary Outcomes (5)

  • Severity of chemotherapy induced-peripheral neuropathy

    At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

  • Evaluation of change in electromyography (EMG) parameters

    At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

  • Evaluation of change in electromyography (EMG) parameters

    At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

  • Impact of PN on patients' quality of life

    At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

  • Evaluation of change in level of disability

    At baseline, after the 20th session of the rehabilitation program, follow up at 3 months

Study Arms (2)

Peripheral neuropathies patients

Peripheral neuropathies patients will be assessed at baseline, after a 20 session 2-3/w program of physical therapy and at a follow up of 3 months with: * Total Neuropathy Score-clinical version (TNSc©) * Nerve conduction studies * Short Form Health Survey 36 (SF-36) * Functional Independence Measure (FIM) * postural evaluation recording during three different postural tasks (quiet standing, voluntary sway and shoulder flexion):centre of pressure (COP) displacement of force platform; surface muscle activation using electromyography (EMG) of 13 muscle on the right side of the body (tibialis anterior, soleus,gastrocnemius lateralis-medialis, biceps femoris, semitendinosus, rectus femoris, vastus lateralis and medialis, tensor fasciae latae, lumbar and thoracic erector spinae and rectus abdominis) * Six Minute Walking Test (6MWT), Mini Balance Evaluation System Test (MiniBESTest) and Timed Up and Go test (TUG).

Other: Rehabilitation program

Healthy age-matched subjects

Healthy age-matched subjects will receive a postural evaluation recording during three different postural tasks (quiet standing, voluntary sway and shoulder flexion): * centre of pressure (COP) displacement of force platform; * surface muscle activation using electromyography (EMG) of 13 muscle on the right side of the body (tibialis anterior, soleus,gastrocnemius lateralis-medialis, biceps femoris, semitendinosus, rectus femoris, vastus lateralis and medialis, tensor fasciae latae, lumbar and thoracic erector spinae and rectus abdominis).

Interventions

The exercise intervention will consist of an individualized prescription of resistance training, balance training and cardiovascular exercises delivered for 20 session, one-hour, two/three times per week.

Peripheral neuropathies patients

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Peripheral neuropathy patients sent for a neurologic evaluation

You may qualify if:

  • Subject suffering from peripheral neuropathy with a TNSc© score more than 4
  • male and female subjects who are 18 years of age or older

You may not qualify if:

  • orthopedic or neurologic comorbidities that can influence postural control
  • A control group of healthy subjects with the same demographic features of peripheral neuropathy patients wil be also included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cecilia Perin

Carate Brianza, Monza E Brianza, 20841, Italy

NOT YET RECRUITING

Paola Alberti

Monza, Monza E Brianza, 20900, Italy

RECRUITING

MeSH Terms

Conditions

Peripheral Nervous System Diseases

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

Neuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Paola ALberti, MD, PhD

    Università degli Studi di Milano Bicocca

    PRINCIPAL INVESTIGATOR
  • Cecilia Perin, MD

    Università degli Studi di Milano Bicocca

    PRINCIPAL INVESTIGATOR
  • Guido Cavaletti, MD

    Università degli Studi di Milano Bicocca

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2021

First Posted

October 22, 2021

Study Start

September 3, 2021

Primary Completion

April 1, 2024

Study Completion

April 1, 2024

Last Updated

January 2, 2024

Record last verified: 2023-12

Locations